Literature DB >> 16141419

Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations.

Heather J Fullerton1, Achal S Achrol, S Claiborne Johnston, Charles E McCulloch, Randall T Higashida, Michael T Lawton, Stephen Sidney, William L Young.   

Abstract

BACKGROUND AND
PURPOSE: Children with brain arteriovenous malformations (BAVMs) are said to be at higher risk for intracranial hemorrhage (ICH) than adults. Although this notion affects treatment decisions, the evidence to support this claim is limited.
METHODS: To compare the risk of ICH in children versus adults with BAVM, we studied all cases of BAVM evaluated at the University of California, San Francisco (January 2000 to December 2004; n=400) and Kaiser Permanente Northern California (January 1993 to December 2004; n=819). In Kaplan-Meier survival analyses, the index date was the date of initial BAVM detection; cases were censored at time of subsequent ICH (the primary outcome, defined as ICH after initial presentation), first BAVM treatment, or loss to follow-up. Cox proportional hazards models included childhood presentation (<20 years old), hemorrhagic presentation, and other potential confounders.
RESULTS: Our study included 996 person-years of follow-up in the childhood presentation group and 3260 in the adult presentation group. In the unadjusted survival analysis, the subsequent ICH rates were similar for the 2 age groups (average annual rate 2.0% for children; 2.2% for adults; P=0.82 by log-rank test). BAVMs in childhood were more likely to present initially with ICH (P<0.001). After adjustment for presentation in the multivariate model, subsequent ICH rates were lower in children (hazard ratio, 0.10; 95% CI, 0.01 to 0.86; P=0.036).
CONCLUSIONS: Children with BAVMs do not appear to be at increased risk for a subsequent ICH compared with adults, and may even be relatively protected. Confounding by hemorrhagic presentation should be considered in any study comparing BAVM hemorrhage rates in children versus adults.

Entities:  

Mesh:

Year:  2005        PMID: 16141419     DOI: 10.1161/01.STR.0000181746.77149.2b

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  36 in total

1.  Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations.

Authors:  Ludmila Pawlikowska; K Y Trudy Poon; Achal S Achrol; Charles E McCulloch; Connie Ha; Kristen Lum; Jonathan G Zaroff; Nerissa U Ko; S Claiborne Johnston; Stephen Sidney; Douglas A Marchuk; Michael T Lawton; Pui-Yan Kwok; William L Young
Journal:  Neurosurgery       Date:  2006-05       Impact factor: 4.654

2.  Clinical, radiological profile and outcome in pediatric Spetzler-Martin grades I-III arteriovenous malformations.

Authors:  Anup P Nair; Raj Kumar; Anant Mehrotra; A K Srivastava; Rabi Narayan Sahu; Prakash Nair
Journal:  Childs Nerv Syst       Date:  2012-01-21       Impact factor: 1.475

3.  Seizure predictors and control after microsurgical resection of supratentorial arteriovenous malformations in 440 patients.

Authors:  Dario J Englot; William L Young; Seunggu J Han; Charles E McCulloch; Edward F Chang; Michael T Lawton
Journal:  Neurosurgery       Date:  2012-09       Impact factor: 4.654

Review 4.  Familial occurrence of brain arteriovenous malformations: a systematic review.

Authors:  J van Beijnum; H B van der Worp; H M Schippers; O van Nieuwenhuizen; L J Kappelle; G J E Rinkel; J W Berkelbach van der Sprenkel; C J M Klijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-26       Impact factor: 10.154

5.  Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture.

Authors:  Helen Kim; Charles E McCulloch; S Claiborne Johnston; Michael T Lawton; Stephen Sidney; William L Young
Journal:  Am J Epidemiol       Date:  2010-05-14       Impact factor: 4.897

6.  [Intracranial vascular malformations].

Authors:  D F Vollherbst; M Bendszus; M A Möhlenbruch
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

Review 7.  Hemorrhagic stroke in children.

Authors:  Lori C Jordan; Argye E Hillis
Journal:  Pediatr Neurol       Date:  2007-02       Impact factor: 3.372

8.  Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment.

Authors:  Achal S Achrol; Helen Kim; Ludmila Pawlikowska; K Y Trudy Poon; Charles E McCulloch; Nerissa U Ko; S Claiborne Johnston; Michael W McDermott; Jonathan G Zaroff; Michael T Lawton; Pui-Yan Kwok; William L Young
Journal:  Neurosurgery       Date:  2007-10       Impact factor: 4.654

Review 9.  Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations.

Authors:  W Caleb Rutledge; Nerissa U Ko; Michael T Lawton; Helen Kim
Journal:  Transl Stroke Res       Date:  2014-06-15       Impact factor: 6.829

10.  Radiosurgery of brain arteriovenous malformations in children.

Authors:  D R Buis; C M F Dirven; F J Lagerwaard; E S Mandl; G J Lycklama A Nijeholt; D S Eshghi; R van den Berg; J C Baayen; O W M Meijer; B J Slotman; W P Vandertop
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.